chlamydial exoglycolipid antigen

oral immunization with an anti-idiotypic antibody to GLXA protects against experimental Chlamydia trachomatis infection; shed in the medium of infected cells

Also Known As:

GLXA (antigen)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Bacterial Polysaccharides: 50
    - chlamydial exoglycolipid antigen: 1
- Glycoconjugates: 1353
  - Glycolipids: 2799
    - chlamydial exoglycolipid antigen: 1
Lipids: 114793
- Glycolipids: 2799
  - chlamydial exoglycolipid antigen: 1
Biological Factors: 2472
- Antigens: 143924
  - Bacterial Antigens: 807
    - Bacterial Polysaccharides: 50
      - chlamydial exoglycolipid antigen: 1

Related Diseases

1.	Infections 10/01/1996 - "A monoclonal anti-idiotypic antibody (anti-Id) to the chlamydial exoglycolipid antigen (GLXA) was tested in a murine model of ocular chlamydial infection for its ability to induce systemic immunity, which reduces microbiologic and clinical disease. "